GE HealthCare Technologies Inc.

Listed Company

GEHCCIK 0001932393NasdaqLarge AcceleratedX-Ray Apparatus & Tubes & Related Irradiation ApparatusDelawareFY ends Dec 31

Period

FY 2025

Revenue

$20.63B

Net Income

$2.08B

Total Assets

$36.91B

Equity

$10.38B

Shares Out

454.89M

Op. Cash Flow

$1.99B

Business

GE HealthCare Technologies Inc. is a global healthcare solutions provider that develops medical technology, pharmaceutical diagnostics, and integrated AI-enabled digital and data analytics solutions. It offers medical imaging and ultrasound systems, patient monitoring and life support devices, contrast media and radiopharmaceuticals, consumables, service contracts, and software including AI-based clinical decision support and PACS. The company operates four reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. It sells products and services through direct sales teams, distributors, and a multi-channel global commercial model serving customers in over 160 countries.

Summary from filing dated 2025-02-13

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenues	20,625	19,672	19,552	18,341	17,585
Gross profit	8,248	8,205	7,922	7,179	7,174
Selling, general, and administrative	4,225	4,269	4,282	3,631	3,563
Research and development	1,260	1,311	1,205	1,026	816
Total operating expenses	5,485	5,580	5,487	4,657	4,379
Operating income	2,763	2,625	2,435	2,522	2,795
Interest and other financial charges net	440	504	542	77	40
Non-operating benefit (income) costs	−288	−406	−382	−5	3
Other (income) expense net	−157	−55	−86	−62	−123
Income from continuing operations before income taxes	2,768	2,581	2,361	2,512	2,875
Benefit (provision) for income taxes	−614	−531	−743	−563	−600
Net income from continuing operations	2,154	2,050	1,618	1,949	2,275
Income (loss) from discontinued operations, net of taxes	0	0	−4	18	18
Net income	2,154	2,050	1,614	1,967	2,293
Net (income) loss attributable to noncontrolling interests	−70	−57	−46	−51	−46
Net income attributable to GE HealthCare	2,084	1,993	1,568	1,916	2,247
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	−183	0	0
Net income attributable to GE HealthCare common stockholders	2,084	1,993	1,385	1,916	2,247
Basic (in dollars per share)	4.56	4.37	3.06	4.18	4.91
Diluted (in dollars per share)	4.55	4.34	3.04	4.18	4.91
Basic (in dollars per share)	4.56	4.37	3.05	4.22	4.95
Diluted (in dollars per share)	4.55	4.34	3.03	4.22	4.95
Basic (in shares)	456	456	455	454	454
Diluted (in shares)	458	459	458	454	454

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash, cash equivalents, and restricted cash	4,512	2,889	2,504	1,445	—
Receivables net of allowances of $103 and $103	3,955	3,566	—	—	—
Inventories	2,234	1,939	1,960	2,155	—
Contract and other deferred assets	1,073	974	1,000	989	—
All other current assets	726	532	389	417	—
Current assets	12,501	9,901	9,410	8,318	—
Property, plant, and equipment net	3,092	2,550	2,500	2,314	—
Goodwill	13,489	13,136	12,936	12,813	12,892
Other intangible assets net	1,130	1,078	1,253	1,520	—
Deferred income taxes	4,491	4,474	4,474	1,550	—
All other non-current assets	2,205	1,950	1,881	1,024	—
Total assets	36,906	33,089	32,454	27,539	—
Short-term borrowings	508	1,502	1,006	15	—
Accounts payable	3,250	3,035	2,947	2,944	—
Contract liabilities	2,095	1,943	1,918	1,896	—
Current compensation and benefits	1,666	1,521	1,518	—	—
All other current liabilities	1,587	1,552	—	—	—
Current liabilities	9,105	9,553	8,981	7,191	—
Long-term borrowings	9,495	7,449	8,436	8,234	—
Non-current compensation and benefits	5,453	5,583	5,782	549	—
Deferred income taxes	193	56	68	370	—
All other non-current liabilities	2,061	1,796	1,877	1,603	—
Total liabilities	26,307	24,437	25,144	17,947	—
Commitments and contingencies	—	—	—	—	—
Redeemable noncontrolling interests	209	188	165	230	220
Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 458,844,209 shares issued as of December 31, 2025; 457,246,971 shares issued as of December 31, 2024	5	5	5	0	—
Treasury stock, at cost, 3,107,626 shares as of December 31, 2025 and 291,053 shares as of December 31, 2024	−225	−25	0	—	—
Additional paid-in capital	6,707	6,583	6,493	0	—
Retained earnings	5,281	3,262	1,326	0	—
Accumulated other comprehensive income (loss) net	−1,388	−1,379	−691	−1,878	—
Total equity attributable to GE HealthCare	10,379	8,446	7,133	9,357	—
Noncontrolling interests	11	18	12	5	—
Total equity	10,390	8,464	7,145	9,362	16,676
Total liabilities, redeemable noncontrolling interests, and equity	36,906	33,089	32,454	27,539	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation of property, plant, and equipment	287	268	248	228	225
Amortization of intangible assets	291	312	362	405	400
Gain on remeasurement of Nihon Medi-Physics equity method investment	−97	0	0	—	—
Net periodic postretirement benefit plan (income) expense	−267	−357	−332	9	25
Postretirement plan contributions	−338	−332	−357	−18	−20
Share-based compensation	130	125	114	67	76
Cash paid during the year for income taxes	−429	−491	−474	−851	−615
Receivables	−216	−157	−173	−231	−1,336
Inventories	−142	−81	111	−402	−435
Contract and other deferred assets	−60	3	10	−222	23
Accounts payable	90	60	−100	481	263
Contract liabilities	81	68	26	138	−21
Current compensation and benefits	94	39	153	−37	—
All other operating activities net	−204	−83	151	140	11
Cash from (used for) operating activities continuing operations	1,987	1,955	2,101	2,134	1,607
Additions to property, plant and equipment and internal-use software	−482	−401	−387	−310	−248
Dispositions of property, plant, and equipment	0	0	1	4	15
Purchases of businesses, net of cash acquired	−378	−313	−147	0	−1,481
Purchases of investments	−118	−40	−48	−59	—
All other investing activities net	−69	−160	23	−33	−47
Cash from (used for) investing activities continuing operations	−1,047	−914	−558	−398	−1,761
Net increase (decrease) in borrowings (maturities of 90 days or less)	1	0	−12	9	−7
Newly issued debt, net of debt issuance costs (maturities longer than 90 days)	2,734	995	2,006	8,198	5
Repayments and other reductions (maturities longer than 90 days)	−1,767	−1,418	−855	−3	−10
Dividends paid to stockholders	−64	−55	−41	0	0
Repurchase of common stock	−200	0	0	—	—
Redemption of noncontrolling interests	0	0	−211	0	0
Net transfers (to) from GE	0	0	−1,317	−8,934	−238
Proceeds from stock issued under employee benefit plans	37	33	34	0	—
Taxes paid related to net share settlement of equity awards	−42	−93	−33	0	—
All other financing activities net	−81	−34	−49	−92	−13
Cash from (used for) financing activities continuing operations	617	−573	−478	−822	−263
Cash from (used for) operating activities discontinued operations	0	−4	0	−21	0
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash	66	−77	−10	−3	−34
Increase (decrease) in cash, cash equivalents, and restricted cash	1,623	387	1,055	890	−451
Cash paid during the year for interest	−522	−550	−570	0	−21
Acquired but unpaid property, plant, and equipment	164	143	140	136	93

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro